Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane

Cancer Lett. 1997 Dec 23;121(2):211-6. doi: 10.1016/s0304-3835(97)00358-3.

Abstract

The influence of concomitant administration of bovine lactoferrin (bLF) on induction of aberrant crypt foci (ACF) by azoxymethane was investigated in male F344 rats. Two percent bLF and 3% Bifidobacterium longum (B. longum), as a positive control, significantly decreased the numbers of ACF as well as the total numbers of aberrant crypts reproducibly in three independent studies (2% bLF, P < 0.01; 3% B. longum, P < 0.05). Most importantly large size foci composed of four or more crypts were always significantly decreased by 2% bLF (P < 0.05). Additional investigation of the natural killer activity of spleen cells demonstrated enhancement by bLF (P < 0.01) and B. longum (P < 0.01) in line with the levels of influence on foci induction, indicating a possible role for elevated immune cytotoxicity in the observed inhibition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticarcinogenic Agents / therapeutic use*
  • Azoxymethane / toxicity*
  • Bifidobacterium / physiology
  • Carcinogens / toxicity*
  • Chemoprevention
  • Colonic Neoplasms / chemically induced
  • Colonic Neoplasms / immunology
  • Colonic Neoplasms / prevention & control*
  • Drug Administration Schedule
  • Killer Cells, Natural / immunology*
  • Lactoferrin / therapeutic use*
  • Male
  • Neoplasm Staging
  • Precancerous Conditions / chemically induced
  • Precancerous Conditions / immunology
  • Precancerous Conditions / prevention & control
  • Rats
  • Rats, Inbred F344

Substances

  • Anticarcinogenic Agents
  • Carcinogens
  • Lactoferrin
  • Azoxymethane